These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 2040166

  • 1. Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users.
    Brill K, Norpoth T, Schnitker J, Albring M.
    Contraception; 1991 Feb; 43(2):101-10. PubMed ID: 2040166
    [Abstract] [Full Text] [Related]

  • 2. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.
    Endrikat J, Müller U, Düsterberg B.
    Contraception; 1997 Mar; 55(3):131-7. PubMed ID: 9115000
    [Abstract] [Full Text] [Related]

  • 3. Long-term experience with a low-dose oral contraceptive.
    Brill K, Schnitker J, Albring M.
    Gynecol Endocrinol; 1990 Dec; 4(4):277-86. PubMed ID: 2150581
    [Abstract] [Full Text] [Related]

  • 4. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
    Rekers H.
    Acta Obstet Gynecol Scand; 1988 Dec; 67(2):171-4. PubMed ID: 2972160
    [Abstract] [Full Text] [Related]

  • 5. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
    Kirkman RJ, Pedersen JH, Fioretti P, Roberts HE.
    Contraception; 1994 Jan; 49(1):33-46. PubMed ID: 8137624
    [Abstract] [Full Text] [Related]

  • 6. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
    Koetsawang S, Charoenvisal C, Banharnsupawat L, Singhakovin S, Kaewsuk O, Punnahitanont S.
    Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587
    [Abstract] [Full Text] [Related]

  • 7. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles.
    Bannemerschult R, Hanker JP, Wünsch C, Fox P, Albring M, Brill K.
    Contraception; 1997 Nov; 56(5):285-90. PubMed ID: 9437556
    [Abstract] [Full Text] [Related]

  • 8. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M, Røde A, Westergaard J.
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [Abstract] [Full Text] [Related]

  • 9. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
    Gaspard UJ, Deville JL, Dubois M.
    Curr Med Res Opin; 1983 Sep; 8(6):395-404. PubMed ID: 6406157
    [Abstract] [Full Text] [Related]

  • 10. Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.
    Endrikat J, Düsterberg B, Ruebig A, Gerlinger C, Strowitzki T.
    Contraception; 1999 Nov; 60(5):269-74. PubMed ID: 10717778
    [Abstract] [Full Text] [Related]

  • 11. Open prospective multicenter trial with a new monophasic contraceptive combination containing gestodene.
    Renier M, Buytaert P.
    Contraception; 1991 May; 43(5):413-21. PubMed ID: 1914456
    [Abstract] [Full Text] [Related]

  • 12. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.
    Weber-Diehl F, Lehnert J, Lachnit U.
    Contraception; 1993 Oct; 48(4):291-301. PubMed ID: 8222658
    [Abstract] [Full Text] [Related]

  • 13. Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol.
    Lammers P, op ten Berg M.
    Acta Obstet Gynecol Scand; 1991 Oct; 70(6):497-500. PubMed ID: 1837199
    [Abstract] [Full Text] [Related]

  • 14. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W, Foidart JM, Dombrovicz N, Welter A, Heithecker R.
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [Abstract] [Full Text] [Related]

  • 15. The effect on blood pressure of a monophasic oral contraceptive containing ethinylestradiol and gestodene.
    Fuchs N, Düsterberg B, Weber-Diehl F, Mühe B.
    Contraception; 1995 Jun; 51(6):335-9. PubMed ID: 7554972
    [Abstract] [Full Text] [Related]

  • 16. Clinical tolerance of a combined monophasic contraceptive agent containing a low-dose of ethinyloestradiol and gestodene in adolescents.
    Leonard F, Gaspard U, Theunissen L.
    Curr Med Res Opin; 1993 Jun; 13(2):78-86. PubMed ID: 8325045
    [Abstract] [Full Text] [Related]

  • 17. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA, Bonnar J.
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [Abstract] [Full Text] [Related]

  • 18. The acceptance of a 7-week cycle with a modern low-dose oral contraceptive (Minulet).
    Kornaat H, Geerdink MH, Klitsie JW.
    Contraception; 1992 Feb; 45(2):119-27. PubMed ID: 1559335
    [Abstract] [Full Text] [Related]

  • 19. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.
    Fioretti P, Fruzzetti F, Navalesi R, Ricci C, Miccoli R, Cerri M, Orlandi MC, Melis GB.
    Contraception; 1987 Mar; 35(3):229-43. PubMed ID: 2956055
    [Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiol.
    Gauthier A, Upmalis D, Dain MP.
    Acta Obstet Gynecol Scand Suppl; 1992 Mar; 156():27-32. PubMed ID: 1324554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.